IMIS

A new integrated search interface will become available in the next phase of marineinfo.org.
For the time being, please use IMIS to search available data

 

[ report an error in this record ]basket (1): add | show Print this page
one publication added to basket [381053]
Per- and polyfluoroalkyl substances (PFAS) and immune system-related diseases: results from the Flemish Environment and Health Study (FLEHS) 2008–2014
van Larebeke, N.; Koppen, G.; De Craemer, S.; Colles, A.; Bruckers, L.; Den Hond, E.; Govarts, E.; Morrens, B.; Schettgen, T.; Remy, S.; Coertjens, D.; Nawrot, T.; Nelen, V.; Baeyens, W.; Schoeters, G. (2023). Per- and polyfluoroalkyl substances (PFAS) and immune system-related diseases: results from the Flemish Environment and Health Study (FLEHS) 2008–2014. Environ. Sci. Eur. 35(1): 28. https://dx.doi.org/10.1186/s12302-023-00731-6
In: Environmental Sciences Europe. Springer: New York. ISSN 2190-4707; e-ISSN 2190-4715, more
Peer reviewed article  
Available in  Authors 
Authors  Top 
  • van Larebeke, N., more
  • Koppen, G.
  • De Craemer, S.
  • Colles, A.
  • Bruckers, L.
  • Den Hond, E.
  • Govarts, E., more
  • Morrens, B.
  • Schettgen, T.
  • Remy, S.
  • Coertjens, D.
  • Nawrot, T.
  • Nelen, V.
  • Baeyens, W., more
  • Schoeters, G., more
Abstract

    Background

    The successive FLEHS campaigns assess internal exposure to pollutants and associated early biological and health effects in participants of different age groups.

    Materials and methods

    Mother–newborn pairs (N = 220 in 2008–2009, age 18–42 years; N = 269 in 2013–2014, age 18–44 years), 197 adolescents 14–15 years (2010–2011), 201 adults 20–40 years (2008–2009) and 205 adults 50–65 years (2014) were recruited. For the various groups of subjects different sets of PFAS were assessed. Perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA) and perfluorobutane sulfonate (PFBS) were determined in cord plasma and peripheral serum as these were the PFAS compounds for which we had access to high quality measurements and which were expected to be present in the highest concentrations. Participants filled out a questionnaire based on the European Community Respiratory Health Survey questionnaire on asthma and allergy. In these cross-sectional studies associations were assessed using stepwise multiple logistic regression, with confounders (including smoking and familial occurrence of the disease) and potential covariates selected on the basis of experience in our previous studies and a literature search. Forest plots of odds ratios summarize the associations between the various PFAS on the one hand and the different immune outcomes on the other hand.

    Results

    For several self-reported immune system-related diseases inverse associations with PFAS serum concentrations were observed. These inverse associations were more pronounced in mothers and adults than in adolescents. A significant inverse association was observed in adults and mothers (for mothers based on measurements on cord plasma) between PFNA, PFOS, and PFHxS and asthma (for mothers also for PFOA), in mothers between PFHxS, PFNA and PFOS and allergic rhinitis, in mothers and adults between PFHxS and PFOS and some forms of allergy (for mothers also for PFOA), in adults between PFOA and eczema, and in adolescents between PFOS and systemic allergy.

    Conclusion

    Internal exposure to PFAS was associated with changes in immunological processes consistent with what has been reported in the literature. Whereas these changes were observed in many publications to be associated with adverse health effects, our findings suggest that they can also lead to inverse associations with certain immune system-related diseases.
All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors